Elevance Health Inc (NYSE: ELV) is -19.76% lower on its value in year-to-date trading and has touched a low of $379.29 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELV stock was last observed hovering at around $385.56 in the last trading session, with the day’s loss setting it -7.17%.
Currently trading at $378.39, the stock is -5.03% and -11.26% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.72 million and changing -1.86% at the moment leaves the stock -24.71% off its SMA200. ELV registered -21.74% loss for a year compared to 6-month loss of -29.77%. The firm has a 50-day simple moving average (SMA 50) of $428.9168 and a 200-day simple moving average (SMA200) of $503.22546.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.36% gain in the last 1 month and extending the period to 3 months gives it a -31.31%, and is -3.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.23% over the week and 2.29% over the month.
Elevance Health Inc (ELV) has around 104900 employees, a market worth around $87.76B and $174.01B in sales. Current P/E ratio is 13.79 and Fwd P/E is 10.83. Profit margin for the company is 3.69%. Distance from 52-week low is -0.24% and -33.30% from its 52-week high. The company has generated returns on investments over the last 12 months (9.37%).
The EPS is expected to grow by 0.12% this year
2327.0 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 92.00% of the company’s shares. The shares outstanding are 231.93M, and float is at 231.44M with Short Float at 1.22%. Institutions hold 91.82% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.1134 of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.8976 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.005 and valued at over $6.31 billion, while STATE STREET CORP holds 4.5373 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider sale by Kendrick Charles Morgan JR, the company’s EVP & President, Commercial. SEC filings show that Kendrick Charles Morgan JR sold 7,417 shares of the company’s common stock on Oct 18 ’24 at a price of $432.14 per share for a total of $3.21 million. Following the sale, the insider now owns 8423.0 shares.
Still, SEC filings show that on Aug 05 ’24, PERU RAMIRO G (Director) disposed off 753 shares at an average price of $531.52 for $0.4 million. The insider now directly holds 8,744 shares of Elevance Health Inc (ELV).
